Johnson & Johnson: Vital Signs Decent, A Compelling Value Case [Seeking Alpha]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Seeking Alpha
I have a buy rating on Johnson & Johnson (JNJ) given its stable earnings growth and lofty yield. JNJ's diversified portfolio and pipeline provide stability, despite some weaknesses in certain areas. I highlight key price points to monitor on the chart ahead of a busy corporate presentation schedule. The Health Care sector continues to meander, while more risk-on areas of the stock market hit fresh record highs. In the last three months, the Health Care Select Sector SPDR ETF ( XLV ) is among three S&P 500 sector ETFs Recommended For You Recommended For You About JNJ Stock More on JNJ Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (NYSE: JNJ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $175.00 price target on the stock.MarketBeat
- Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer [Yahoo! Finance]Yahoo! Finance
- Subcutaneous amivantamab Biologics License Application submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancerPR Newswire
- Johnson & Johnson's nipocalimab shows promise in Sjögren's disease trial [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 6/6/24 - Form 4
- 6/6/24 - Form 4
- 5/28/24 - Form SD
- JNJ's page on the SEC website